SCGB3A2 and neoplasm: Human SCGB3A2(C1) alone showed drastic inhibition of LLC cells growth, while the amount of LPS contained in the recombinant SCGB3A2 preparation C1 or C3, or high concentration did not show any statistically significant differences in tumor numbers compared with PBS administration (Figure 2F).